Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...

We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...

Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.

Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of Seagen. The deal added four antibody-drug conjugates (ADC) — Adcetris, Padcev, ...

American Express stock has been stable but unspectacular this year, staying in lockstep with the broader market. With ...

Morgan Stanley (NYSE:MS) has seen a notable shift in its stock ownership as Massachusetts Financial Services Co. MA reduced ...

Welcome to our live ASX coverage for Thursday, July 17. We’re excited to be trialing this new format. Expect a high volume of ...